Trueplus Diabetics Foot Care

Trueplus Diabetics Foot Care

Trueplus Diabetics Foot Care Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Depo-Provera CI is indicated only for the prevention of pregnancy. The loss of bone mineral density (BMD) in women of all ages and the impact on peak bone mass in adolescents should be considered, along with the decrease in BMD that occurs during pregnancy and/or lactation, in the risk/benefit assessment for women who use Depo-Provera CI long-term [see Warnings and Precautions (5.1)].

History

There is currently no drug history available for this drug.

Other Information

Depo-Provera CI contains medroxyprogesterone acetate, a derivative of progesterone, as its active ingredient. Medroxyprogesterone acetate is active by the parenteral and oral routes of administration. It is a white to off-white; odorless crystalline powder that is stable in air and that melts between 200°C and 210°C. It is freely soluble in chloroform, soluble in acetone and dioxane, sparingly soluble in alcohol and methanol, slightly soluble in ether, and insoluble in water.

The chemical name for medroxyprogesterone acetate is pregn-4-ene-3, 20-dione, 17-(acetyloxy)-6-methyl-, (6α-).

The structural formula is as follows:

Chemical Structure

Depo-Provera CI for intramuscular (IM) injection is available in vials and prefilled syringes, each containing 1 mL of medroxyprogesterone acetate sterile aqueous suspension 150 mg/mL.

For Depo-Provera CI vials, each mL of sterile aqueous suspension contains:
Medroxyprogesterone acetate 150 mg
Polyethylene glycol 3350 28.9 mg
Polysorbate 80 2.41 mg
Sodium chloride 8.68 mg
Methylparaben 1.37 mg
Propylparaben 0.150 mg
Water for injection quantity sufficient
When necessary, pH is adjusted with sodium hydroxide or hydrochloric acid, or both.
For Depo-Provera CI prefilled syringes, each mL of sterile aqueous suspension contains:
Medroxyprogesterone acetate 150 mg
Polyethylene glycol 3350 28.5 mg
Polysorbate 80 2.37 mg
Sodium chloride 8.56 mg
Methylparaben 1.35 mg
Propylparaben 0.147 mg
Water for injection quantity sufficient
When necessary, pH is adjusted with sodium hydroxide or hydrochloric acid, or both.

Trueplus Diabetics Foot Care Manufacturers


  • Nipro Diagnostics, Inc.
    Trueplus Diabetics Foot Care (Allantoin And Dimethicone) Cream [Nipro Diagnostics, Inc.]

Login To Your Free Account